Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px

News > All

Total search results: 17093 | Ordered by Date (descending)
1 2 3 ... 169 170 171  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Premaitha Health plc. (9/19/18). "Press Release: Legal Settlement and Licence Agreement with Illumina". Manchester. 2018-09-19
Apeiron Biologics AG. (9/19/18). "Press Release: Apeiron Announces Collaboration with Lead Discovery Center GmbH". Vienna. 2018-09-19
Argen-X N.V. (Argenx). (9/19/18). "Press Release: Argenx Raises approximately $300.6 Million in Gross Proceeds in a U.S. Public Offering". Breda & Ghent. 2018-09-19
Medicines Discovery Catapult, The. (9/19/18). "Press Release: Novel Deep Learning Drug Discovery Platform Gets £1 Million Innovation boost. Optibrium, Intellegens and Medicines Discovery Catapult Awarded Funding to Apply Machine Learning in Drug Discover 2018-09-19
GeNeuro S.A.. (9/18/18). "Press Release: GeNeuro Regains Worldwide Rights ex US and Japan to GNbAC1 in Multiple Sclerosis from Servier". Paris & Geneva. 2018-09-18
BRAIN AG. (9/18/18). "Press Release: BRAIN AG Announces Strategic Research Collaboration with BluCon Biotech GmbH". Zwingenberg & Cologne. 2018-09-18
Neurimmune AG. (9/18/18). "Press Release: Neurimmune Achieves Milestone in Collaboration with Ono Pharmaceutical". Schlieren. 2018-09-18
Horama S.A.. (9/18/18). "Press Release: Horama Completes Its 22.5 Million Euros Series B Financing Round". Paris. 2018-09-18
Qiagen N.V.. (9/17/18). "Press Release: Qiagen and NeuMoDx Announce Strategic Partnership to Offer Next-generation Systems for Fully Integrated Molecular Diagnostic Testing". Hilden & Ann Arbor, MI. 2018-09-17
Qiagen N.V.. (9/17/18). "Press Release: Qiagen and DiaSorin Launch Automated Testing for Latent TB Infection with QuantiFERON-TB Gold Plus Technology on Widely Used Liaison Platforms". Hilden & Saluggia. 2018-09-17
GamaMabs Pharma S.A.. (9/17/18). "Press Release: GamaMabs Pharma Starts a Phase 2 Study of Monoclonal Antibody GM102 in Patients with Advanced or Metastatic Colorectal Cancer". Paris & Toulouse. 2018-09-17
Argen-X N.V. (Argenx). (9/17/18). "Press Release: Argenx Announces Launch of Proposed Public Offering in the United States". Breda & Ghent. 2018-09-17
Evotec AG. (9/17/18). "Press Release: Evotec and Almirall Enter into Research Collaboration in the Field of Dermatiological Diseases". Hamburg & Barcelona. 2018-09-17
CRISPR Therapeutics AG. (9/17/18). "Press Release: CRISPR Therapeutics and ViaCyte Announce Strategic Collaboration to Develop Gene-Edited Stem Cell-Derived Therapy for Diabetes". Zug, Cambridge, MA & San Diego, CA. 2018-09-17
BIA Separations d.o.o.. (9/17/18). "Press Release: BIA Separations Expands with New Upstream Processing Facility". Ajdovšcina. 2018-09-17
Cancer Research UK. (9/17/18). "Press Release: London Biotherapeutics Powerhouse Launched by Cancer Research UK". 2018-09-17
Argen-X N.V. (Argenx). (9/17/18). "Press Release: Argenx Reports Positive Topline Results from Phase 2 Proof-of-Concept Trial of Efgartigimod in Primary Immune Thrombocytopenia". Breda & Ghent. 2018-09-17
Sphere Fluidics Ltd.. (9/17/18). "Press Release: Sphere Fluidics Introduces New Cyto-Mine Studio Software Suite". Cambridge. 2018-09-17
Metrion Biosciences Ltd.. (9/17/18). "Press Release: Metrion Biosciences Makes Senior Appointments to Strengthen Its Drug Discovery Leadership tTeam". Cambridge. 2018-09-17
Sanofi S.A.. (9/15/18). "Press Release: Positive Phase 3 Results Presented for Dupixent (dupilumab) Show Significant Improvement on Multiple Measures of Disease Severity in Adolescents with Moderate-to-Severe Atopic Dermatitis". Paris & Tarrytown, NY. 2018-09-15
Horizon Discovery Group plc. (9/14/18). "Press Release: Horizon Discovery Edit-R crRNA Libraries Adopted by AstraZeneca as Part of Its Functional Genomics Discovery Platform". Cambridge. 2018-09-14
ViraTherapeutics GmbH. (9/13/18). "Press Release: Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies". Ingelheim. 2018-09-13
Galapagos N.V.. (9/13/18). "Press Release: Galapagos Raises $300 Million Gross Proceeds in a U.S. Public Offering". Mechelen. 2018-09-13
MorphoSys AG. (9/13/18). "Press Release: MorphoSys and Galapagos Announce Start of a Phase 1 Subcutaneous Bridging Study with MOR106". Planegg & Mechelen. 2018-09-13
Sanofi S.A.. (9/13/18). "Press Release: Sanofi to Refocus Two Global Business Units". Paris. 2018-09-13
Wacker Chemie AG. (9/13/18). "Press Release: Wacker Invests in Jena Biotech Site". Jena. 2018-09-13
Targovax ASA. (9/13/18). "Press Release: Targovax Strengthens Management Team With the Appointment of Torbjørn Furuseth as CFO; Erik Digman Wiklund to become CBO". Oslo. 2018-09-13
Qiagen N.V.. (9/12/18). "Press Release: Qiagen to Join Germany’s MDAX Index in Addition to TecDAX". Hilden & Germantown, MD. 2018-09-12
University of Oxford. (9/12/18). "Press Release: Novo Nordisk Research Centre Opens in Oxford". 2018-09-12
Neurimmune AG. (9/12/18). "Press Release: Neurimmune Appoints Christoph Hock as Chief Medical Officer to Lead Clinical Development". Schlieren. 2018-09-12
Galapagos N.V.. (9/12/18). "Press Release: Galapagos Announces Launch of Proposed Public Offering". Mechelen. 2018-09-12
Boehringer Ingelheim. (9/12/18). "Press Release: Biosimilar Cyltezo Demonstrates Clinical equivalence to Humira® in Patients with Moderate-to-Severe Plaque Psoriasis". Ingelheim. 2018-09-12
Optibrium Ltd.. (9/11/18). "Press Release: Optibrium and Intellegens Collaborate to Apply Novel Deep Learning Methods to Drug Discovery". Cambridge. 2018-09-11
European Commission. (9/11/18). "Press Release: European List of Strategic Research infrastructures Expands into New Areas". Vienna. 2018-09-11
Neovacs S.A.. (9/11/18). "Press Release: Neovacs Announces that Its Partner Biosense Global Has Exercised Its Option to Acquire the Exclusive Licence for IFNalpha Kinoid to Treat Lupus in China". Paris & Boston, MA. 2018-09-11
Crescendo Biologics Ltd.. (9/11/18). "Press Release: Crescendo Biologics Strengthens its Management with the Appointment of Dr Pavel Pisa as Chief Medical Officer". Cambridge. 2018-09-11
Cell and Gene Therapy Catapult, The. (9/11/18). "Press Release: Stevenage Cell and Gene Therapy Catapult Centre Gets Green Light to Make New Cell and Gene Therapies". 2018-09-11
Galapagos N.V.. (9/11/18). "Press Release: Gilead and Galapagos Announce Filgotinib Meets Primary and All Key Secondary Endpoints in First Phase 3 Study in Rheumatoid Arthritis". Foster City, CA & Mechelen. 2018-09-11
MolMed S.p.A.. (9/11/18). "Press Release: MolMed Appoints Mr. Salvatore Calabrese Chief Financial Officer". Milan. 2018-09-11
University of Glasgow. (9/11/18). "Press Release: Cutting-edge Electron Microscope Revealed at Opening of New £5m Structural Biology Centre". 2018-09-11
Ilya Pharma AB. (9/10/18). "Press Release: Ilya Pharma Raises Additional Euro 3 Million to Take Novel ATMP through to Phase II for Wound Care". 2018-09-10
Pieris Pharmaceuticals, Inc.. (9/10/18). "Press Release: Pieris Pharmaceuticals Appoints Peter Kiener, D.Phil., to its Board of Directors". Boston, MA. 2018-09-10
RSP Systems A/S. (9/10/18). "Press Release: RSP Systems Adds EUR 3.85 Million in a Second Closing of its Series B Funding Round, Increasing the Round Total to EUR 10.35 Million". Odense. 2018-09-10
F-Star Biotechnology Ltd.. (9/10/18). "Press Release: F-star Appoints Nessan Bermingham as Chairman of its Board of Directors". Cambridge. 2018-09-10
Fluidigm Corporation. (9/10/18). "Press Release: Fluidigm Announces Co-Marketing Agreement with Visiopharm to Expand and Simplify Imaging Mass Cytometry Data Analysis". South San Francisco, CA. 2018-09-10
Definiens AG. (9/10/18). "Press Release: Definiens Embarks on Digital Pathology Collaboration with Merck's Exploratory and Clinical Development Programs". Munich. 2018-09-10
Arecor Ltd.. (9/10/18). "Press Release: Arecor Secures £6m Investment for the Clinical Development of Its Diabetes Speciality Pharma Portfolio". Cambridge. 2018-09-10
Haplogen Bioscience GmbH. (9/10/18). "Press Release: Cyclenium Pharma and Haplogen Bioscience Announce Granting of EUREKA Label and Funding to Develop Novel Therapies in Severe Viral Diseases". Montréal, QC & Vienna. 2018-09-10
Lunaphore Technologies S.A.. (9/9/18). "Press Release: Menarini Will Bring Lunaphore’s Ultra-Rapid Tissue Staining Solution LabSat Frozen to Market". Lausanne & Florence. 2018-09-09
European Invesmtent Bank (EIB). (9/7/18). "Press Release: Investment Plan for Europe – the EIB and Grifols Sign a New Loan Agreement to Advance Research on Rare and Chronic Diseases". 2018-09-07
Visiopharm A/S. (9/7/18). "Press Release: Launching Phenomap Multiplexing". 2018-09-07
BTG plc. (9/7/18). "Press Release: BTG plc Acquires Novate Medical Ltd.". 2018-09-07
Polyphor Ltd.. (9/6/18). "Press Release: Polyphor Announces Financial Results for the First Half 2018". Allschwil. 2018-09-06
Evotec AG. (9/6/18). "Press Release: Evotec and Celgene Enter Partnership in the Field of Targeted Protein Degradation". Hamburg. 2018-09-06
Devicare S.L.. (9/6/18). "Press Release: Devicare Gets the Patent for Its Sensor Technology in Europe and USA". 2018-09-06
Novartis AG. (9/6/18). "Press Release: Novartis to Divest the Sandoz US Dermatology Business and Generic US Oral Solids Portfolio to Aurobindo". Basel. 2018-09-06
Allogene Therapeutics, Inc.. (9/6/18). "Press Release: Allogene Therapeutics Completes a $120 Million Private Financing". South San Francisco, CA. 2018-09-06
Evotec AG. (9/6/18). "Press Release: Evotec AG Listed in MDAX". Hamburg. 2018-09-06
MorphoSys AG. (9/6/18). "Press Release: MorphoSys AG to Be Listed in MDAX". Planegg. 2018-09-06
Medigene AG. (9/6/18). "Press Release: Medigene Announces Inclusion in SDAX". Planegg. 2018-09-06
Polyphor Ltd.. (9/6/18). "Press Release: Novo Holdings Invests CHF 6.8 Million in Polyphor to Accelerate the Development of Novel Antibiotics against Multi-drug Resistant Gram-negative Pathogens". Allschwil & Copenhagen. 2018-09-06
Argen-X N.V. (Argenx). (9/6/18). "Press Release: Argenx Doses First Patient in Global Phase 3 Registration Trial of Efgartigimod". Breda & Ghent. 2018-09-06
Adocia S.A.. (9/5/18). "Press Release: Adocia Announces Positive Topline Results for the First Clinical Study of BioChaperone Pramlintide Insulin in People with Type 1 Diabetes". Lyon. 2018-09-05
Adaptimmune Therapeutics plc. (9/5/18). "Press Release: Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares". Philadeliphia, PA & Oxford. 2018-09-05
Probiodrug AG. (9/4/18). "Press Release: Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy". Halle (Saale). 2018-09-04
Miracor Medical S.A.. (9/4/18). "Press Release: Miracor Medical Closes Final Tranche of Series D, Bringing the Round to €30M". Awans. 2018-09-04
Arix Bioscience plc. (9/4/18). "Press Release: Changes Announced to Executive Team to Accelerate Growth and Strategy". London. 2018-09-04
Pieris Pharmaceuticals, Inc.. (9/4/18). "Press Release: Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy". Boston, MA. 2018-09-04
Optibrium Ltd.. (9/4/18). "Press Release: Optibrium and Enamine Collaboration Extends Commercial Compound Database Access for StarDrop Users". Cambridge & Kiev. 2018-09-04
Azeria Therapeutics Ltd.. (9/4/18). "Press Release: Azeria Therapeutics, the World's First Pioneer Factor Drug Discovery Company, Announces Series A Investment from Sixth Element Capital". Cambridge. 2018-09-04
NTrans Technologies B.V.. (9/4/18). "Press Release: NTrans Technologies Receives Horizon 2020 SME Grant". 2018-09-04
Abivax S.A.. (9/4/18). "Press Release: Abivax Reports Impressive Results in Clinical Phase 2a Trial of ABX464 as an Oral Treatment for Ulcerative Colitis Patients". Paris. 2018-09-04
Sanofi S.A.. (9/4/18). "Press Release: Sanofi Reaches Civil Settlement with US SEC". Paris. 2018-09-04
Eurofins. (9/4/18). "Press Release: Eurofins Expands Its Leading Global Cosmetic Testing Footprint with the Acquisition of Clinical Research Laboratories in North America". 2018-09-04
AiCuris Anti-infective Cures GmbH. (9/3/18). "Press Release: AiCuris Reports Positive Phase 1 Clinical Trial Results with Immunomodulator AIC649 in Patients with Chronic Hepatitis B". Wuppertal. 2018-09-03
Sanofi S.A.. (9/3/18). "Press Release: Cablivi (caplacizumab) Approved in Europe for Adults with Acquired Thrombotic Thrombocytopenic Purpura (aTTP)". Paris. 2018-09-03
EuropaBio. (9/3/18). "Press Release: EuropaBio Appoints New Secretary General, Healthcare Director and Industrial Biotech Director". Brussels. 2018-09-03
Evox Therapeutics Ltd.. (9/3/18). "Press Release: Evox Therapeutics Completes £35.5 Million Series B Financing". Oxford. 2018-09-03
Tecan Group Ltd.. (9/3/18). "Press Release: Tecan Successfully Completes the Acquisition of NuGen Technologies". Männedorf. 2018-09-03
Boehringer Ingelheim. (9/3/18). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Supports BeiGene in Its China NDA Submission of anti-PD-1 Antibody, Tislelizumab". Shanghai. 2018-09-03
BRAIN AG. (8/31/18). "Press Release: BRAIN AG Reports Growth for the First Nine Months of the 2017/18 Financial Year". Zwingenberg. 2018-08-31
EMD Serono. (8/31/18). "Press Release: Rehan Verjee to Lead EMD Serono as Company Advances its Innovative Medicines Strategy in North America". Rockland, MA. 2018-08-31
Medigene AG. (8/31/18). "Press Release: Medigene Announces Change in Executive Leadership Team". Planegg. 2018-08-31
Novartis Pharma GmbH. (8/31/18). "Pressemitteilung: Novartis und das Fraunhofer IZI geben Kooperation in der CAR-T Zelltherapie für Patienten in Europa bekannt". Leipzig & Nürnberg. 2018-08-31
Alnylam Pharmaceuticals, Inc.. (8/30/18). "Press Release: Alnylam Receives Approval of Onpattro (patisiran) in Europe". Cambridge, MA. 2018-08-30
Genomics plc. (8/30/18). "Press Release: Vertex and Genomics plc Establish Collaboration to Use Human Genetics and Data Science to Advance Discovery of Precision Medicines". Boston, MA & Oxford. 2018-08-30
Genomics Medicine Ireland Ltd.. (8/30/18). "Press Release: Genomics Medicine Ireland and University of Cambridge Announce Multiple Sclerosis Research Collaboration". Dublin. 2018-08-30
Enzymicals AG. (8/30/18). "Press Release: Enzymicals AG Extends Its Capacity in Business Development". 2018-08-30
GlaxoSmithKline plc. (8/30/18). "Press Release: European Commission Approves Nucala (mepolizumab) for the Treatment of Children with Severe Asthma". London. 2018-08-30
Immuneed AB. (8/30/18). "Press Release: Ultimovacs Acquires the Immunotherapy Technology Business of Immuneed AB for NOK 50 Million". 2018-08-30
CiToxLab S.A.. (8/30/18). "Press Release: CiToxLab Appoints Christophe Berthoux as CEO, Europe". Evreux. 2018-08-30
Lunaphore Technologies S.A.. (8/30/18). "Press Release: Lunaphore Closes a CHF 5.3M Series B Financing Round". Lausanne. 2018-08-30
BRAIN AG. (8/30/18). "Press Release: DOLCE Core Team Announces Membership Changes in Programme for Natural-based Sweeteners". Zwingenberg. 2018-08-30
Genomics plc. (8/30/18). "Press Release: Genomics plc Raises £25 million in Series B Round to Advance Its Use of Human Genetics and Data Science in Drug Discovery". Oxford. 2018-08-30
Adocia S.A.. (8/30/18). "Press Release: Adocia Announces Update to Second Arbitration Against Eli Lilly & Company". Lyon. 2018-08-30
Probiodrug AG. (8/30/18). "Press Release: Probiodrug Reports Financial Results for H1 2018 and Corporate Update". Halle (Saale). 2018-08-30
Evotec AG. (8/30/18). "Press Release: Evotec and CHDI Foundation Extend Ongoing Collaboration to Fight Huntington’s Disease". Hamburg. 2018-08-30
EBD Group. (8/30/18). "Press Release: Global Life Sciences to Convene in Copenhagen for Europe's Largest Annual Biopharma Partnering Conference". Carlsbad, CA & Copenhagen. 2018-08-30
Bayer AG. (8/30/18). "Press Release: Bayer Receives US Approval for Modern Hemophilia A Treatment Jivi with a Step-wise Prophylaxis Dosing Regimen [Not intended for U.S. and UK Media]". Berlin. 2018-08-30
Orchard Therapeutics Ltd.. (8/29/18). "Press Release: Orchard Therapeutics Expands Leadership Team with Appointments of Head of Corporate Communications and Head of Human Resources". Boston, MA & London. 2018-08-29
1 2 3 ... 169 170 171  next pagenext page



Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October 600x60px

» top